Success Metrics

Clinical Success Rate
100.0%

Based on 6 completed trials

Completion Rate
100%(6/6)
Active Trials
0(0%)
Results Posted
50%(3 trials)

Phase Distribution

Ph phase_2
1
17%
Ph phase_3
1
17%
Ph phase_4
3
50%
Ph phase_1
1
17%

Phase Distribution

1

Early Stage

1

Mid Stage

4

Late Stage

Phase Distribution6 total trials
Phase 1Safety & dosage
1(16.7%)
Phase 2Efficacy & side effects
1(16.7%)
Phase 3Large-scale testing
1(16.7%)
Phase 4Post-market surveillance
3(50.0%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

100.0%

6 of 6 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

0

trials recruiting

Total Trials

6

all time

Status Distribution
Completed(6)

Detailed Status

Completed6

Development Timeline

Analytics

Development Status

Total Trials
6
Active
0
Success Rate
100.0%
Most Advanced
Phase 4

Trials by Phase

Phase 11 (16.7%)
Phase 21 (16.7%)
Phase 31 (16.7%)
Phase 43 (50.0%)

Trials by Status

completed6100%

Recent Activity

0 active trials
Showing 5 of 6
completedphase_3

Effects of Acute Long-acting Bronchodilation on Oxygenation and Peripheral Ventilation in COPD

NCT05927155
completedphase_4

INTREPID: Investigation of TRELEGY Effectiveness: Usual Practice Design

NCT03467425
completedphase_4

Longitudinal Cohort Study in Participants With Severe Asthma to Assess Biomarkers

NCT02537691
completedphase_4

Study to Evaluate the Efficacy and Safety of Glycopyrronium or Indacaterol Maleate and Glycopyrronium Bromide Fixed-dose Combination Regarding Symptoms and Health Status in Patients With Moderate COPD Switching From Treatment With Any Standard COPD Regimen

NCT01985334
completedphase_1

A Study to Evaluate the Safety and Use of Human Rhinovirus in Healthy and Asthmatic Participants (MK-0000-218)

NCT01866306
View all 6 trials

Clinical Trials (6)

Showing 6 of 6 trials
NCT05927155Phase 3

Effects of Acute Long-acting Bronchodilation on Oxygenation and Peripheral Ventilation in COPD

Completed
NCT03467425Phase 4

INTREPID: Investigation of TRELEGY Effectiveness: Usual Practice Design

Completed
NCT02537691Phase 4

Longitudinal Cohort Study in Participants With Severe Asthma to Assess Biomarkers

Completed
NCT01985334Phase 4

Study to Evaluate the Efficacy and Safety of Glycopyrronium or Indacaterol Maleate and Glycopyrronium Bromide Fixed-dose Combination Regarding Symptoms and Health Status in Patients With Moderate COPD Switching From Treatment With Any Standard COPD Regimen

Completed
NCT01866306Phase 1

A Study to Evaluate the Safety and Use of Human Rhinovirus in Healthy and Asthmatic Participants (MK-0000-218)

Completed
NCT01948401Phase 2

A Study to Measure Serum Periostin, Asthma-Related Biomarkers and Response to Prednisolone in Adult and Adolescent Patients With Severe Oral Corticosteroid-Dependent Asthma

Completed

All 6 trials loaded

Drug Details

Intervention Type
DRUG
Total Trials
6